Drugs / GLSE compound
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02603016 | Nov 2015 → Nov 2016 | breast neoplasm, lung neoplasm | Chinese PLA General Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GLSE compound | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02603016 ↗ |
| Route | Oral | “GLSE compound 2g each time by mouth” NCT02603016 ↗ |